Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size
Open Access
- 1 January 2011
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 11 (Suppl 3) , S16
Abstract
Diarrhea mortality remains a leading cause of child death and rotavirus vaccine an effective tool for preventing severe rotavirus diarrhea. New data suggest vaccine efficacy may vary by region.Keywords
This publication has 22 references indexed in Scilit:
- Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control studyBMJ, 2010
- Global, regional, and national causes of child mortality in 2008: a systematic analysisThe Lancet, 2010
- Standards for CHERG reviews of intervention effects on child survivalInternational Journal of Epidemiology, 2010
- The effect of rotavirus vaccine on diarrhoea mortalityInternational Journal of Epidemiology, 2010
- Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled studyVaccine, 2009
- Rotavirus and Severe Childhood DiarrheaEmerging Infectious Diseases, 2006
- Grading quality of evidence and strength of recommendationsBMJ, 2004
- Rotavirus vaccine for preventing diarrhoeaCochrane Database of Systematic Reviews, 2004